Hey, TechCrunch people. If you’re looking for a recap of the week’s news in tech, you’ve come to the right place. It’s Week in Review (WiR) , TechCrunch’s regular recap column. Glad to have you. Before we get on with the meat of it, a PSA that tickets for TechCrunch Disrupt 2023 are available now. Disrupt, of course, is TechCrunch’s flagship in-person event, focused on founders, investors and the future of tech year after year. In San Francisco on September 19–21, expect to hear from thought leaders in the fields of AI, fintech, hardware, sustainability, SaaS, security and more. It’ll be well worth the trip. In the nearer term, tune into the next TechCrunch Live show, which will spotlight Cambrian BioPharma, a startup billing itself as a pharmaceutical outfit with a revolutionary approach to managing drug development. Founder James Peyer will be joined by Maryanna Saenko of Future Ventures, who invested in Cambrian’s Series A, B and C rounds. Now, without further ado! most read E...